<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32505118</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study.</ArticleTitle><Pagination><StartPage>102298</StartPage><MedlinePgn>102298</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102298</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2020.102298</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(20)30135-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Diffusion tensor imaging (DTI) can identify amyotrophic lateral sclerosis (ALS)-associated patterns of brain alterations at the group level according to a neuropathological staging system.</AbstractText><AbstractText Label="OBJECTIVE">The study was designed to investigate the in vivo staging in ALS patients with the C9orf72 expansion and potential differences to ALS patients with the SOD1 mutation.</AbstractText><AbstractText Label="METHODS">DTI-based white matter mapping was performed both by an unbiased voxel-wise statistical comparison and by a hypothesis-guided tract-wise analysis of fractional anisotropy (FA) maps according to the ALS-staging pattern for 27 ALS patients with C9orf72 expansion vs 15 ALS patients with SOD1 mutation vs 32 matched healthy controls. Clinical and neuropsychological data were acquired and correlated to DTI data.</AbstractText><AbstractText Label="RESULTS">The analysis of white matter integrity demonstrated regional FA reductions along the CST and also in frontal and prefrontal brain areas according to the proposed propagation pattern for the ALS patients with C9orf72 expansion and sporadic patients. This pattern could not be identified for the SOD1 mutation at the group level. In contrast, in the tract-specific analysis according to the neuropathological ALS-staging pattern, C9orf72 expansion ALS patients showed significant alterations of ALS-related tract systems similar to sporadic patients.</AbstractText><AbstractText Label="CONCLUSIONS">The DTI study including the tract-of-interest-based analysis showed a microstructural corticoefferent involvement pattern according to the staging scheme in C9orf72-associated ALS patients but not in the SOD1 mutation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Tredici</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lul&#xe9;</LastName><ForeName>Doroth&#xe9;e</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Germany. Electronic address: jan.kassubek@uni-ulm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72 expansion</Keyword><Keyword MajorTopicYN="N">Diffusion tensor imaging</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Motor neuron diseases</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32505118</ArticleId><ArticleId IdType="pmc">PMC7270604</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2020.102298</ArticleId><ArticleId IdType="pii">S2213-1582(20)30135-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahams S., Newton J., Niven E. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler. Frontotemporal Degener. 2014;15:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Ferraro P.M., Riva N. Structural and functional brain signatures of C9orf72 in motor neuron disease. Neurobiol. Aging. 2017;57:206&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">28666709</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Spinelli E.G., Marjanovic I.V. Unraveling ALS due to SOD1 mutation through the combination of brain and cervical cord MRI. Neurology. 2018;90:e707&#x2013;e716.</Citation><ArticleIdList><ArticleId IdType="pubmed">29367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Omer T., Finegan E. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018;12:1696&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C. Amyotrophic lateral sclerosis &#x2013; a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Neumann M., Ludolph A.C., Del Tredici K. Does sporadic amyotrophic lateral sclerosis spread via axonal connectivities? Neurol. Int. Open. 2017;1:E136&#x2013;E141.</Citation></Reference><Reference><Citation>Brenner D., Weishaupt J.H. Update on amyotrophic lateral sclerosis genetics. Curr. Opin. Neurol. 2019;32:735&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">31335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Elamin M., Bede P. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Kantarci K. Imaging biomarkers for neurodegeneration in presymptomatic familial frontotemporal lobar degeneration. Front. Neurol. 2020;11:80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058699</ArticleId><ArticleId IdType="pubmed">32184751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Calvo A., Moglia C. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J. Neurol. Neurosurg. Psychiatry. 2011:82,740e746.</Citation><ArticleIdList><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F. ExpandedGGGGCC hexanucleotide repeat in noncoding region of C9orf72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Feis R.A., Bouts M.J.R.J., Panman J.L. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. Neuroimage Clin. 2019;22</Citation></Reference><Reference><Citation>Floeter M.K., Gendron T.F. Biomarkers for amyotrophic lateral sclerosis and frontotemporal dementia associated with hexanucleotide expansion mutations in C9orf72. Front. Neurol. 2018;9:1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289985</ArticleId><ArticleId IdType="pubmed">30568632</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter M.K., Danielian L.E., Braun L.E., Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J. Neurol. Neurosurg. Psychiatry. 2018;89:53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454927</ArticleId><ArticleId IdType="pubmed">29054917</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002;15:870&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">11906227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra, S., M&#xfc;ller, H.P., Ishaque, A., et al., 2020. A prospective harmonized multicentre DTI study of cerebral white matter degeneration in ALS. Neurology. in press.</Citation></Reference><Reference><Citation>Kassubek J., M&#xfc;ller H.P. Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis. Expert Rev. Neurother. 2020;20:237&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">31937156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., M&#xfc;ller H.P., Del Tredici K. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain. 2014;137:1733&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., M&#xfc;ller H.P., Del Tredici K. Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J. Neurol. Neurosurg. Psychiatry. 2018;89:374&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunimatsu A., Aoki S., Masutani Y. The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn. Reson. Med. Sci. 2004;3:11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16093615</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bihan D., Mangin J.F., Poupon C. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging. 2001;13:534&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">11276097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A., Drory V., Hardiman O. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;29:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Brettschneider J. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease? Eur. J. Neurol. 2015;22:753&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">25846565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D., Burkhardt C., Abdulla S. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller, H.P., Unrath, A., Ludolph, A.C., et al., 2007A. Preservation of diffusion tensor properties during spatial normalisation by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol. 52,N99-109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17327646</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller, H.P., Unrath, A., Sperfeld, A.D., et al. 2007B. Diffusion tensor imaging and tractwise fractional anisotropy statistics: quantitative analysis in white matter pathology. Biomed Eng Online. 6,42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2186341</ArticleId><ArticleId IdType="pubmed">17996104</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Unrath A., Riecker A. Intersubject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques. Magn. Reson. Imag. 2009;27:324&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">18701228</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Gr&#xf6;n G., Sprengelmeyer R. Evaluating multicenter DTI data in Huntington's disease on site specific effects: an ex post facto approach. Neuroimage Clin. 2013;2:161&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3777841</ArticleId><ArticleId IdType="pubmed">24179771</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Turner M.R., Grosskreutz J. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2016;87:570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Kassubek J. MRI-Based mapping of cerebral propagation in amyotrophic lateral sclerosis. Front. Neurosci. 2018;12:655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168650</ArticleId><ArticleId IdType="pubmed">30319338</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Agosta F., Riva N. Fast progressive lower motor neuron disease is an ALS variant: a two-centre tract of interest-based MRI data analysis. Neuroimage Clin. 2018;17:145&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651542</ArticleId><ArticleId IdType="pubmed">29071208</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Gorges M., Kassubek R. Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: a tract of interest-based MRI study. Neuroimage Clin. 2018;18:762&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959739</ArticleId><ArticleId IdType="pubmed">29785360</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Agosta F., Gorges M. Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis. Neuroimage Clin. 2018;20:1062&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6198122</ArticleId><ArticleId IdType="pubmed">30343251</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.P., Gorges M., Del Tredici K. The same cortico-efferent tract involvement in progressive palsy and in 'classical' ALS: a tract of interest-based MRI study. Neuroimage Clin. 2019;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6706345</ArticleId><ArticleId IdType="pubmed">31421506</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer T., Finegan E., Hutchinson S. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2017;18:611&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallebage-Gamarallage M., Foxley S., Menke R.A.L. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. BMC Neurosci. 2018;19:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5848544</ArticleId><ArticleId IdType="pubmed">29529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Isaacs A.M., Mizielinska S. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015;14:291&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A., M&#xfc;ller H.P., H&#xfc;bers A. Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study. J. Neurol. 2016;263:2430&#x2013;2437.</Citation><ArticleIdList><ArticleId IdType="pubmed">27624123</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A., M&#xfc;ller H.P., Riecker A. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum. Brain Mapp. 2010;31:1727&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871219</ArticleId><ArticleId IdType="pubmed">20336652</ArticleId></ArticleIdList></Reference><Reference><Citation>Waibel S., Neumann M., Rabe M. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology. 2010;75:815&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pubmed">20660363</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.J., Walhout R., Straathof M. Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. J. Neurol. Neurosurg. Psychiatry. 2016;87:1354&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136726</ArticleId><ArticleId IdType="pubmed">27756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Zhang H., Alexander D.C. Neurite density is reduced in the presymptomatic phase of C9orf72 disease. J. Neurol. Neurosurg. Psychiatry. 2019;90:387&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">30355607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L., M&#xfc;ller K., Khalaji S. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>